IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

SR One Capital Management, LP

Q2 2022 Holdings

Filed 2022-08-02 | 4 holdings | $204.3K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Arcellx Inc.(ACLX)COMMON STOCK03940C100$99.4K5,500,00748.7%
Design Therapeutics Inc(DSGN)COM25056L103$78.8K5,626,47638.6%
Nkarta Inc.(NKTX)COM65487U108$16.4K1,333,3338.0%
Effector Therapeutics IncCOM28202V108$9.7K6,822,1144.7%